Genprex, Inc. (GNPX): Insider Trading, Congress Trades & Research | Tormere

GNPX

$1.95+7.73%download financials (.py)

Genprex, Inc.

Market Cap

$975,000

Live price × shares (2026-10-17)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

-0.90

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Price / TTM revenue

P/B

0.1

Price / stockholders equity

EV/EBITDA

—

TTM

Price Chart

Loading…

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

8

recent articles

Analyst Consensus

Strong Buy

7 analysts

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-04-14	2026-04-15	LONGNECKER BRENT M	Director	Sale	18	$1.23	$22.14	0	View

Recent News

Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA®, in Maintaining Cellular Function During Brain Aging

Yahoo Finance · 2026-10-21

Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Yahoo Finance · 2026-09-08

Andelyn Biosciences to Scale Manufacturing for Genprex's Diabetes Gene Therapy Program

Yahoo Finance · 2026-09-01

Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy

Yahoo Finance · 2026-08-18

Genprex Shares Rise After Collaboration With Roche Diagnostics

Yahoo Finance · 2026-08-03

Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies

Yahoo Finance · 2026-08-03

Genprex’s Reqorsa combo secures Canadian patent for lung cancer

Yahoo Finance · 2026-06-23

Genprex to Participate at BIO International Convention 2026

Yahoo Finance · 2026-06-17

Informational purposes only, not investment advice.